• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems.

作者信息

Abizaid Alexandre, Costa J Ribamar

机构信息

Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.

出版信息

Circ Cardiovasc Interv. 2010 Aug;3(4):384-93. doi: 10.1161/CIRCINTERVENTIONS.109.891192.

DOI:10.1161/CIRCINTERVENTIONS.109.891192
PMID:20716758
Abstract
摘要

相似文献

1
New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems.新型药物洗脱支架：可生物降解及无聚合物的下一代支架系统概述
Circ Cardiovasc Interv. 2010 Aug;3(4):384-93. doi: 10.1161/CIRCINTERVENTIONS.109.891192.
2
Biodegradable polymers--are they the answer to late stent thrombosis? Too early to tell.
Catheter Cardiovasc Interv. 2008 Aug 1;72(2):184-5. doi: 10.1002/ccd.21692.
3
Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents.可生物降解聚合物涂层西罗莫司洗脱支架的长期临床、血管造影及血管内超声结果
Catheter Cardiovasc Interv. 2008 Aug 1;72(2):177-83. doi: 10.1002/ccd.21600.
4
BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease.生物基质生物雷帕霉素A9洗脱冠状动脉支架：用于冠状动脉疾病的新一代药物洗脱支架。
Expert Rev Med Devices. 2006 Nov;3(6):731-41. doi: 10.1586/17434440.3.6.731.
5
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial.生物可降解聚合物洗脱雷帕霉素支架与耐用聚合物洗脱西罗莫司支架用于冠状动脉血运重建的比较（LEADERS）：一项随机非劣效性试验
Lancet. 2008 Sep 27;372(9644):1163-73. doi: 10.1016/S0140-6736(08)61244-1. Epub 2008 Aug 31.
6
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.可生物降解聚合物涂层西罗莫司洗脱支架在“真实世界”实践中的安全性和有效性：18个月临床及9个月血管造影结果
JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013.
7
Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.生物可吸收依维莫司洗脱冠状动脉支架与依维莫司洗脱钴铬冠状动脉支架体内急性支架回缩的比较：来自ABSORB和SPIRIT试验的见解。
Catheter Cardiovasc Interv. 2007 Oct 1;70(4):515-23. doi: 10.1002/ccd.21136.
8
Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.生物可吸收聚合物与耐用聚合物载药及裸金属支架的临床疗效：来自综合网络荟萃分析的证据。
J Am Coll Cardiol. 2014 Feb 4;63(4):299-307. doi: 10.1016/j.jacc.2013.09.061. Epub 2013 Nov 6.
9
A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results.前瞻性多中心平行对照试验：TIVOLI 可生物降解聚合物西罗莫司洗脱支架与 ENDEAVOR 佐他莫司洗脱支架治疗冠状动脉疾病的比较：8 个月血管造影和 2 年临床随访结果。
Chin Med J (Engl). 2011 Mar;124(6):811-6.
10
Randomized evaluation of two drug-eluting stents with identical metallic platform and biodegradable polymer but different agents (paclitaxel or sirolimus) compared against bare stents: 1-year results of the PAINT trial.随机评价两种药物洗脱支架，它们具有相同的金属平台和可生物降解聚合物，但药物不同（紫杉醇或西罗莫司），与裸支架相比：PAINT 试验的 1 年结果。
Catheter Cardiovasc Interv. 2009 Nov 1;74(5):665-73. doi: 10.1002/ccd.22166.

引用本文的文献

1
Carbon Dot-Enhanced Doxorubicin Liposomes: A Dual-Functional Nanoplatform for Cancer Therapy.碳点增强型阿霉素脂质体：一种用于癌症治疗的双功能纳米平台。
Int J Mol Sci. 2025 Aug 4;26(15):7535. doi: 10.3390/ijms26157535.
2
Human Metabolism of Sirolimus Revisited.西罗莫司的人体代谢再探讨。
Metabolites. 2025 Jul 20;15(7):489. doi: 10.3390/metabo15070489.
3
Long-Term (5-Years) Outcomes of Current Drug-Eluting Stents in Percutaneous Coronary Intervention: A Network Meta-Analysis of Randomized Controlled Trials.经皮冠状动脉介入治疗中当前药物洗脱支架的长期（5年）疗效：随机对照试验的网状Meta分析
Catheter Cardiovasc Interv. 2025 Aug;106(2):1196-1211. doi: 10.1002/ccd.31668. Epub 2025 Jun 5.
4
A comparison of endothelial cell growth on commercial coronary stents with and without laser surface texturing.带有和不带有激光表面纹理处理的商用冠状动脉支架上内皮细胞生长的比较。
Heliyon. 2024 Feb 19;10(5):e26425. doi: 10.1016/j.heliyon.2024.e26425. eCollection 2024 Mar 15.
5
A Study of PLA Thin Film on SS 316L Coronary Stents Using a Dip Coating Technique.使用浸涂技术对316L不锈钢冠状动脉支架上的聚乳酸薄膜进行的研究。
Polymers (Basel). 2024 Jan 19;16(2):284. doi: 10.3390/polym16020284.
6
A randomized control trial to assess optical coherence tomography parameters of the Xlimus drug-eluting stent: the XLIMIT trial.一项评估Xlimus药物洗脱支架光学相干断层扫描参数的随机对照试验：XLIMIT试验。
Front Cardiovasc Med. 2023 Sep 6;10:1199475. doi: 10.3389/fcvm.2023.1199475. eCollection 2023.
7
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE).聚合物自由型超小径薄支架 BIOrapid（BIOVITESSE）的前瞻性、多中心首例人体研究。
EuroIntervention. 2022 Jun 3;18(2):e132-e139. doi: 10.4244/EIJ-D-21-00537.
8
Predicting the In Vivo Performance of Cardiovascular Biomaterials: Current Approaches In Vitro Evaluation of Blood-Biomaterial Interactions.预测心血管生物材料的体内性能：目前的体外血液-生物材料相互作用评估方法。
Int J Mol Sci. 2021 Oct 21;22(21):11390. doi: 10.3390/ijms222111390.
9
Modification of the surface nanotopography of implant devices: A translational perspective.植入装置表面纳米形貌的修饰：转化医学视角
Mater Today Bio. 2021 Oct 21;12:100152. doi: 10.1016/j.mtbio.2021.100152. eCollection 2021 Sep.
10
Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty .纳米载体介导的西罗莫司与肝素联合疗法可抑制球囊血管成形术后再狭窄。
Nanomedicine (Lond). 2020 May;15(12):1205-1220. doi: 10.2217/nnm-2020-0028. Epub 2020 Apr 28.